乳房假体置入抗菌预防实践模式:美国全国调查
该研究于2015年4月通过SurveyMonkey向美国整形外科学会(ASPS)会员发放20题问卷,评估乳房假体置入中预防假体相关感染的实践模式,共收到253份回复。结果显示抗菌预防措施各环节存在异质性,但整体呈现向减少细菌污染方向调整的趋势;作者认为需要高级别研究以制定标准化循证实践指南。
要点
- 多数术者使用氯己定消毒术区(45%),并以三联抗生素溶液浸泡假体(40%)和冲洗假体腔隙(47%)。
- 42%的术者采用Keller漏斗实施无接触技术。
- 术后抗生素以第一代头孢菌素为主(79%),最常见使用疗程为4至6天(45%)。
核心结论
- 乳房假体置入的抗菌预防在具体环节上存在异质性,但实践模式明显趋向于预防细菌污染。
- 术者可能受益于旨在制定标准化循证实践指南的高级别研究。
研究设计与样本
- 研究为基于问卷调查的横断面实践模式评估。
- 问卷共20题,评估预防乳房假体相关感染的实践措施,于2015年4月通过SurveyMonkey发放给美国整形外科学会(ASPS)会员网站所列电子邮箱的会员。
- 共收到253份回复;受访者中81%从事私人执业,平均执业年限21±9年,每年平均实施乳房假体置入69±111例。
主要发现
- 多数术者使用氯己定准备手术部位(45%)。
- 三联抗生素溶液既用于假体置入前浸泡(40%),也用于假体腔隙冲洗(47%)。
- 42%的术者采用Keller漏斗实施无接触技术。
- 术后抗生素以第一代头孢菌素为主(79%),最常见使用疗程为4至6天(45%)。
临床怎么用
- 调查结果可用于对照自身乳房假体置入抗菌预防实践与同行模式。
- 鉴于具体措施证据不足且实践异质,不宜将调查比例直接作为推荐标准。
局限性
- 原文未报告问卷回复率及无应答偏倚分析。
- 原文未报告调查数据的统计比较或证据等级评价。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast augmentation is one of the most commonly performed aesthetic surgery procedures worldwide. Bacterial contamination is of paramount concern due to its role in biofilm formation and capsular contracture. Plastic surgeons have adopted a variety of perioperative interventions in efforts to reduce implant contamination, however definitive evidence supporting these practices is lacking. OBJECTIVE: The goal of this study was to assess current practice patterns aimed at reducing implant-related infections in breast augmentation and comparing them to current evidence-based medicine recommendations. METHODS: A 20-question survey assessing practices aimed at preventing breast implant associated infections was generated and distributed via SurveyMonkey to members of the American Society of Plastic Surgery whose electronic mail addresses were listed on the American Society of Plastic Surgery member website in April 2015. RESULTS: A total of 253 responses were received from the survey. Of the respondents, 81% were in private practice. Respondents averaged 21 ± 9 years in practice, and 69 ± 111 breast augmentations performed per year. A majority of surgeons used Chlorhexidine to prepare the surgical site (45%) and triple antibiotic solution both as a soak for the implant before placement (40%) as well as for implant pocket irrigation (47%). A no-touch technique using the Keller Funnel was adopted by 42% of surgeons. Regarding antibiotic use in the postoperative period, first-generation cephalosporins were used by the majority of respondents (79%), and the most common duration was for 4 to 6 days (45%). CONCLUSIONS: Although there is heterogeneity in specific aspects of antimicrobial prophylaxis during breast augmentation, there is a clear trend toward practice modification geared towards preventing bacterial contamination in breast augmentation. Surgeons may benefit from high-level studies designed to create standardized evidence-based practice guidelines.
引用
- Chopra K, Gowda AU, McNichols CHL, et al. Antimicrobial Prophylaxis Practice Patterns in Breast Augmentation: A National Survey of Current Practice. Ann Plast Surg. 2017. PMID: 27922894. doi:10.1097/SAP.0000000000000942
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。